Found: 29
Select item for more details and to access through your institution.
Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 791, doi. 10.1007/s10637-019-00742-2
- By:
- Publication type:
- Article
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 207, doi. 10.1007/s10637-016-0411-2
- By:
- Publication type:
- Article
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 641, doi. 10.1007/s10637-015-0229-3
- By:
- Publication type:
- Article
Erratum to: Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 677, doi. 10.1007/s10637-012-9860-4
- By:
- Publication type:
- Article
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 298, doi. 10.1016/j.clcc.2023.05.002
- By:
- Publication type:
- Article
Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
- Published in:
- Journal of Palliative Medicine, 2015, v. 18, n. 11, p. 977, doi. 10.1089/jpm.2015.0203
- By:
- Publication type:
- Article
Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 224, doi. 10.1038/s41416-023-02493-7
- By:
- Publication type:
- Article
A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
- Published in:
- Ecancermedicalscience, 2018, v. 12, n. 844-874, p. 1, doi. 10.3332/ecancer.2018.847
- By:
- Publication type:
- Article
Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer.
- Published in:
- Breast Cancer (13406868), 2017, v. 24, n. 2, p. 312, doi. 10.1007/s12282-016-0705-4
- By:
- Publication type:
- Article
Phase I study of concurrent vinorelbine and radiation therapy in high-risk postmastectomy breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 5, p. 701, doi. 10.1007/s12282-015-0627-6
- By:
- Publication type:
- Article
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0
- By:
- Publication type:
- Article
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y
- By:
- Publication type:
- Article
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 454, doi. 10.1007/s10147-023-02294-1
- By:
- Publication type:
- Article
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1123, doi. 10.1007/s00432-022-03979-2
- By:
- Publication type:
- Article
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
Producing H<sub>2</sub>-Rich Gas from Simulated Biogas and Applying the Gas to a 50W PEFC Stack.
- Published in:
- AIChE Journal, 2004, v. 50, n. 10, p. 2467, doi. 10.1002/aic.10197
- By:
- Publication type:
- Article
Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cam4.7196
- By:
- Publication type:
- Article
Should low-income countries invest in breast cancer screening?
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 4, p. 298, doi. 10.1093/jjco/hyx008
- By:
- Publication type:
- Article
Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1904, doi. 10.3390/cancers16101904
- By:
- Publication type:
- Article
Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 577, doi. 10.1007/s00280-013-2228-4
- By:
- Publication type:
- Article
Muscle wasting associated with the long-term use of mTOR inhibitors.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 5, n. 5, p. 641, doi. 10.3892/mco.2016.1015
- By:
- Publication type:
- Article
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229428
- By:
- Publication type:
- Article